Crescita Therapeutics Inc. CRRTF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

34/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Crescita Therapeutics Inc. (CRRTF) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 32/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

34/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

25/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

28/100

→ Income

GROWTH

40/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — CRRTF

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.53

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-0.14

Book Value / Share$0.00

Revenue / Share$1.02

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2015	$-1.35	$857K	$-15.45M	-1802.6%
2016	$-1.17	$3.5M	$-14.95M	-426.6%
2017	$-0.82	$12.01M	$-11.46M	-95.4%
2018	$0.12	$16.63M	$2.4M	14.4%
2019	$0.08	$22.34M	$1.86M	8.3%
2020	$0.00	$15.64M	$37K	0.2%
2021	$-0.05	$16.77M	$-1.11M	-6.6%
2022	$0.04	$23.53M	$862K	3.7%
2023	$-0.10	$17.52M	$-1.99M	-11.3%
2024	$-0.14	$19.58M	$-2.75M	-14%